Roche launches the cobas eplex respiratory pathogen panel 3, a fast and comprehensive test to help clinicians treat patients with respiratory infections, in CE markets

The new test detects up to 250 viruses and bacteria, including SARS-CoV-2, influenza, Bordetella pertussis, and RSV, in a single patient sample.Rapid results enable doctors to make fast, confident ...
News Medical

Luminex's NxTAG Respiratory Pathogen Panel obtains FDA clearance

Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for its NxTAG® Respiratory Pathogen Panel that detects 20 clinically relevant viral and bacterial respiratory ...
News Medical

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

Luminex Corporation (NASDAQ: LMNX) today announced that it has received CE-IVD marking for its NxTAG® Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial ...
Morningstar

Applied BioCode Submits BioCode® Respiratory Pathogen Panel (RPP) with KingFisher™ Nucleic Acid Extraction Claim to the FDA

Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the KingFisher™ Flex Nucleic Acid Purification System ...
Business Wire

GenMark Receives FDA 510(k) Market Clearance for Its ePlex® Instrument and Respiratory Pathogen Panel

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that it has received 510(k) ...
CNN

GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)

CARLSBAD, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced that its ePlex® ...
Pharmabiz

Luminex seeks US FDA approval for NxTAG respiratory pathogen panel

Luminex Corporation has submitted a 510(k) application to the FDA for the company's NxTAG respiratory pathogen panel. This panel is the only respiratory assay that will easily enable laboratories to ...
GEN

Luminex’ xTAG FAST Assay for Respiratory Pathogens Granted 510(k) Approval

Viral panel is designed to test for eight pathogens in up to 96 patients. FDA granted 510(k) approval to Luminex’ xTAG Respiratory Viral Panel FAST (RVP FAST) test for respiratory infections. Designed ...
Business Wire

Integrated DNA Technologies Launches New Respiratory Virus Panel

CORALVILLE, Iowa--(BUSINESS WIRE)--To meet customer demand for a multiplexed, multiple respiratory disease target panel that provides comprehensive genome coverage, Integrated DNA Technologies (IDT) ...
Medscape

Systematic Viral Testing in Emergency Departments Has Limited Benefit for General Population

Routine use of rapid respiratory virus testing in the emergency department (ED) appears to show limited benefit among patients with signs and symptoms of acute respiratory infection (ARI), according ...
Nasdaq

Integrated DNA Technologies Launches New Respiratory Virus Panel

New ready-to-ship xGen™ NGS solution will enable researchers to combat challenging diseases of today and prepare for the next pathogen of tomorrow Integrated DNA Technologies is revealing a new next ...